Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | I-BET | 1.000 | 0.000 | uM | 72 | hr | 3 | 1357 | 576 | 0.2388 | 0.1880 | 0.4245 | 0.4335 |
COLO 858 | Vemurafenib | I-BET | 1.000 | 0.000 | uM | 72 | hr | 2 | 975 | 407 | 0.1736 | 0.1880 | 0.4174 | 0.4335 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1979 | 884 | 0.0774 | 0.0702 | 0.4467 | 0.4350 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 2 | 1849 | 762 | 0.0769 | 0.0702 | 0.4121 | 0.4350 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 3 | 1434 | 640 | 0.0562 | 0.0702 | 0.4463 | 0.4350 |
COLO 858 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 2 | 904 | 415 | 0.1484 | 0.1822 | 0.4591 | 0.4375 |
COLO 858 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 1 | 1181 | 405 | 0.2356 | 0.1822 | 0.3429 | 0.4375 |
COLO 858 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 3 | 1095 | 559 | 0.1627 | 0.1822 | 0.5105 | 0.4375 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 2 | 1366 | 641 | 0.1307 | 0.1377 | 0.4693 | 0.4424 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1510 | 705 | 0.1452 | 0.1377 | 0.4669 | 0.4424 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1250 | 489 | 0.1372 | 0.1377 | 0.3912 | 0.4424 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 591 | 241 | 0.2157 | 0.2403 | 0.4078 | 0.4433 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 816 | 378 | 0.2699 | 0.2403 | 0.4632 | 0.4433 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 706 | 324 | 0.2354 | 0.2403 | 0.4589 | 0.4433 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 1420 | 605 | 0.1381 | 0.1369 | 0.4261 | 0.4519 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 1647 | 765 | 0.1494 | 0.1369 | 0.4645 | 0.4519 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 1359 | 632 | 0.1232 | 0.1369 | 0.4650 | 0.4519 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1514 | 710 | 0.0955 | 0.1083 | 0.4690 | 0.4526 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1784 | 762 | 0.1213 | 0.1083 | 0.4271 | 0.4526 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1692 | 781 | 0.1082 | 0.1083 | 0.4616 | 0.4526 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 1 | 395 | 154 | 0.2440 | 0.2143 | 0.3899 | 0.4559 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 3 | 366 | 188 | 0.1802 | 0.2143 | 0.5137 | 0.4559 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 2 | 403 | 187 | 0.2187 | 0.2143 | 0.4640 | 0.4559 |
COLO 858 | Vemurafenib | I-BET | 0.316 | 1.000 | uM | 72 | hr | 1 | 1380 | 561 | 0.2504 | 0.2016 | 0.4065 | 0.4572 |
COLO 858 | Vemurafenib | I-BET | 0.316 | 1.000 | uM | 72 | hr | 2 | 1241 | 591 | 0.1987 | 0.2016 | 0.4762 | 0.4572 |